Answers are grounded in this paper and cite their sources.
Introduction: Nonsteroidal anti-inflammatory drugs (NSAIDs) (e.g. indomethacin), administered rectally, seem to be effective in reducing post-ERCP pancreatitis (PEP). This effect seems lost with intramuscularly or intravenously administration. Our aim is to assess whether intravenous ketorolac given as an analgesic to patients with post-procedural abdominal pain reduces the rate of PEP. Material and methods:
No takes yet. Share an insight, caveat, or question.
Mariani et al. (2016) studied this question.
Synapse has enriched 3 related papers. Consider them for comparative context: